Ametek Inc. (0HF7)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 248.82 |
|---|---|
| 52-week range | 184.18 – 266.00 |
| Return, 1 month / 3 months | +5.2% / +4.1% |
| Return, 1 year / 3 years | +33.0% / +70.4% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 23.4% |
| Worst drawdown (1 year) | -13.0% |
| Average daily value traded | 0.23M USD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ametek is an industrial manufacturer based in the United States that makes electronic instruments and electromechanical devices. Its instruments serve customers who need to measure, analyse and control processes in factories, laboratories and energy facilities, while its electromechanical products include motors, blowers and specialty components used in aerospace, medical and industrial equipment. The company supplies these products to original equipment manufacturers and end users across a range of industries around the world.
Ametek Inc. trades under the code 0HF7 on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ametek Inc. (0HF7) trades on the London Exchange in UK. It last closed at USD 248.82 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 858 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.0% and over the last three months it rose 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.8% | ||
| From 52-week high | -3.6% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.1% | ||
| 6-month return | 7.8% | ||
| 12-month return, skipping the last month | 26.4% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.0% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.23M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | +5.2% |
| 3 months | +4.1% |
| 6 months | +7.8% |
| 1 year | +33.0% |
| 3 years | +70.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 244.81 / 233.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Dec 2025 | USD 0.3100 |
| 12 Sep 2025 | USD 0.3100 |
| 12 Jun 2025 | USD 0.3100 |
| 13 Mar 2025 | USD 0.3100 |
| 6 Dec 2024 | USD 0.2800 |
| 13 Sep 2024 | USD 0.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.